• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, June 20, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Virginia Tech Scientist Awarded American Heart Association Fellowship to Investigate Obesity’s Impact on Heart Disease Risk

Bioengineer by Bioengineer
June 4, 2025
in Health
Reading Time: 4 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

blank

In the realm of cardiovascular research, a burgeoning area of interest is coronary microvascular dysfunction—a subtle yet significant condition characterized by impaired blood flow within the heart’s smallest vessels. Mark Renton, a postdoctoral researcher at the Fralin Biomedical Research Institute at Virginia Tech Carilion, is spearheading innovative investigations into this lesser-known but critical facet of heart disease. Supported by a prestigious American Heart Association fellowship, Renton’s work delves deep into the molecular underpinnings of how obesity alters vascular function at the microvascular level, a topic increasingly relevant given the global surge in obesity rates.

Obesity is widely recognized as a cornerstone risk factor for a multitude of cardiovascular diseases, but the intricate biochemical pathways through which it compromises heart health remain incompletely understood. Renton’s research spotlights pannexin-1, a membrane channel protein that plays an instrumental role in vascular signaling. This protein functions as a conduit, permitting ions like ATP to traverse cell membranes and propagate signaling cascades essential for the regulation of vascular tone. By examining how pannexin-1 operates within coronary microvessels, Renton aims to elucidate how obesity might disrupt these mechanisms and precipitate coronary microvascular dysfunction.

The microvasculature of the heart, unlike the larger coronary arteries often implicated in classic heart attack pathophysiology, consists of tiny arterioles and capillaries responsible for finely tuned regulation of blood flow at the cellular level. In many cases, patients develop symptoms such as chest pain and ischemia without evident blockages in major arteries—a clinical presentation increasingly attributed to microvascular abnormalities. Understanding how pannexin-1 influences vessel dilation and constriction provides a molecular window into this enigmatic condition. Recent findings from the lab of Scott Johnstone, under whom Renton works, have shown that the absence or dysfunction of pannexin-1 impairs the vessels’ ability to respond appropriately to physiological signals, mimicking the vascular dysfunction observed in obesity.

.adsslot_nbYJga4pyo{width:728px !important;height:90px !important;}
@media(max-width:1199px){ .adsslot_nbYJga4pyo{width:468px !important;height:60px !important;}
}
@media(max-width:767px){ .adsslot_nbYJga4pyo{width:320px !important;height:50px !important;}
}

ADVERTISEMENT

Fundamentally, pannexin-1 channels are integral to the release of signaling molecules that mediate vascular smooth muscle relaxation and endothelial function. These channels enable communication not only within a single cell but also between neighboring endothelial and smooth muscle cells, coordinating vascular responses systemically. Renton’s project investigates whether obesity-induced metabolic disturbances lead to a reduction in pannexin-1 expression, alterations in the biophysical properties of the channel, or disruptions in the downstream signaling pathways. Such alterations could explain the propensity for vasospasms—sudden, transient constrictions of the blood vessels responsible for angina-like chest pain—and represent a crucial step in the progression of coronary microvascular disease.

Central to this research is the exploration of ion flux and its role in cellular signaling within vascular tissues. Pannexin-1’s unique position on the cell membrane allows it to regulate the extracellular environment dynamically, impacting not only vascular smooth muscle cells but also adjacent cardiomyocytes and perivascular nerves. This multifaceted communication network ensures proper regulation of blood flow corresponding to metabolic demands. Renton postulates that obesity might induce a pathological remodeling of this signaling axis, perhaps through inflammatory mediators or lipid metabolites, resulting in impaired pannexin-1 channel function and therefore compromised microvascular reactivity.

The implications of elucidating this pathway extend far beyond the coronary circulation. Similar pannexin-1-dependent regulatory mechanisms operate in the microvasculature of vital organs such as the brain, liver, and kidneys—organs often adversely affected in obese patients. Therefore, unraveling how obesity alters pannexin-1 function could open avenues for therapeutic interventions targeting multiple organ systems impacted by microvascular complications. The prospect of modifying pannexin-1 channel activity pharmacologically presents a compelling strategy to restore vascular homeostasis and mitigate the heightened cardiovascular risk posed by obesity.

In the context of contemporary cardiovascular medicine, where prevention and early intervention are crucial, Renton’s fellowship-funded research stands to contribute transformative insights. By moving beyond the traditional focus on macroscopic arterial blockages, this work champions a molecular and cellular perspective, emphasizing the significance of microvascular health. The potential development of treatment modalities aimed at preserving pannexin-1 function could redefine clinical approaches to managing obesity-associated heart disease, possibly preventing progression before irreversible damage occurs.

Additionally, this research underscores the intricate interplay between metabolic health and vascular physiology. Obesity is characterized not only by excess adiposity but also by complex metabolic alterations including insulin resistance, chronic inflammation, and oxidative stress. Each of these factors may modulate pannexin-1 activity either directly or indirectly, adding layers of complexity to coronary microvascular dysfunction. Renton’s approach integrates these dimensions, aiming to delineate precise molecular events that link systemic metabolic derangements to localized vascular pathology.

Collaboratively, Renton works alongside leading vascular researchers such as Steven Poelzing and Jessica Pfleger within the institute’s Center for Vascular and Heart Research, fostering a multidisciplinary environment that enhances the translational potential of his findings. This synergy accelerates progress from bench to bedside, facilitating the development of novel diagnostics and therapeutics that could improve patient outcomes comprehensively.

Mark Renton’s investigative trajectory, marked by scientific rigor and innovative thinking, epitomizes the next generation of cardiovascular researchers poised to address the pandemic challenge of obesity-related diseases. With support from the American Heart Association fellowship, he is charting a course toward a deeper understanding of coronary microvascular function and dysfunction, one that promises to unveil new horizons in cardiovascular health and disease management.

As the prevalence of obesity continues to rise worldwide, the urgency to comprehend and combat its deleterious vascular effects intensifies. Renton’s pioneering work on pannexin-1 and coronary microvascular dysfunction embodies a vital stride in this endeavor, holding the promise not only of scientific advancement but also of tangible clinical impact that could benefit millions worldwide.

Subject of Research: Coronary microvascular dysfunction and the molecular impact of obesity on pannexin-1 mediated vascular signaling.

Article Title: Decoding the Molecular Link Between Obesity and Coronary Microvascular Dysfunction: The Role of Pannexin-1

News Publication Date: Not specified.

Web References:
– Fralin Biomedical Research Institute at VTC: https://fbri.vtc.vt.edu/
– Scott Johnstone Lab: https://fbri.vtc.vt.edu/research/labs/johnstone.html
– Center for Vascular and Heart Research: https://fbri.vtc.vt.edu/research/research-centers/center-for-heart.html

Image Credits: Lena Ayuk/Virginia Tech

Keywords: Heart disease, Coronary microvascular dysfunction, Obesity, Pannexin-1, Cardiovascular disorders, Vascular diseases, Molecular mechanisms

Tags: American Heart Association fellowshipbiochemical pathways of obesitycoronary microvascular dysfunctionFralin Biomedical Research Institute researchheart health and obesityinnovative cardiovascular studiesMark Renton researchmicrovascular blood flow impairmentobesity and heart disease riskpannexin-1 protein functionvascular signaling mechanismsVirginia Tech cardiovascular research

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Community-Driven Effort to Advance Parkinson’s Therapies

June 20, 2025
Intensive Outpatient Rehab Boosts Non-Motor PD Outcomes

Intensive Outpatient Rehab Boosts Non-Motor PD Outcomes

June 20, 2025

Ferroptosis in Periodontitis: Mechanisms and Effects

June 20, 2025

Parkinson’s Mutations Impact Dopamine Neurons’ Organelles

June 20, 2025

POPULAR NEWS

  • Green brake lights in the front could reduce accidents

    Study from TU Graz Reveals Front Brake Lights Could Drastically Diminish Road Accident Rates

    161 shares
    Share 64 Tweet 40
  • New Study Uncovers Unexpected Side Effects of High-Dose Radiation Therapy

    76 shares
    Share 30 Tweet 19
  • Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    71 shares
    Share 28 Tweet 18
  • How Scientists Unraveled the Mystery Behind the Gigantic Size of Extinct Ground Sloths—and What Led to Their Demise

    65 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Alzheimer’s Disease Risk in Breast Cancer Survivors: New Insights

Cancer Patients Avoiding Radiation Gain More Time with Loved Ones, Study Finds

Claudia Felser Honored with L’Oréal-UNESCO For Women in Science International Award

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.